BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2426926)

  • 1. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
    Rózalski A; Wykrota M
    Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K; Kaca W; Rózalski A; Deka M
    Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains.
    Rózalski A; Długońska H; Kotełko K
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):505-12. PubMed ID: 3296994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.
    Kotelko K; Rozalski A; Deka M; Kaca W; Sidorczyk Z; Gromska W; Zych K
    Acta Microbiol Pol; 1983; 32(4):339-44. PubMed ID: 6202101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of correlative relations between virulence and other biological properties of Proteus].
    Vitvits'kii VM; Dikii BM
    Mikrobiol Zh; 1975; 37(6):748-51. PubMed ID: 1107766
    [No Abstract]   [Full Text] [Related]  

  • 6. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.
    Peerbooms PG; Verweij AM; MacLaren DM
    J Med Microbiol; 1985 Feb; 19(1):55-60. PubMed ID: 3881591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and properties of haemolysins from clinical isolates of the Proteeae.
    Senior BW; Hughes C
    J Med Microbiol; 1988 Jan; 25(1):17-25. PubMed ID: 3275780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of hydrophobicity of Proteus vulgaris strains and ability of Proteus vulgaris and Proteus penneri strains to penetrate bladder membrane HCV T-29 cells ].
    Bartodziejska B; Błaszczyk A; Wykrota M; Kwil I; Babicka D; Rózalski A
    Med Dosw Mikrobiol; 2002; 54(4):335-45. PubMed ID: 12650056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical studies on the O-antigens of Proteus mirabilis O23 and Proteus vulgaris O23.
    Rózalski A; Perepelov AV; Bartodziejska B; Senchenkova SN; Babicka D; Kaca W; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):69-74. PubMed ID: 12691306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriocinogenic properties of Proteus].
    Shvidenko IG
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):27-30. PubMed ID: 343455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the haemolytic activity of Proteus mirabilis strains.
    Peerbooms PG; Verweij AM; MacLaren DM
    Antonie Van Leeuwenhoek; 1983 Apr; 49(1):1-11. PubMed ID: 6351736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of bacteria of the proteus type in the development of suppurative complications].
    Perfil'ev DF
    Khirurgiia (Mosk); 1972 Sep; 48(9):64-8. PubMed ID: 4575226
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19.
    Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemagglutinating properties of Proteus mirabilis strains isolated from clinical specimens].
    Samet A; Aleksandrowicz I
    Med Dosw Mikrobiol; 1989; 41(2):121-9. PubMed ID: 2685483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The enterotoxigenic capacity of hemolysin-producing strains of Proteus isolated in acute intestinal infections in children].
    Gabidullin ZG; Batyrshin RA; Zhukova SL; Ezepchuk IuV; Sufiiarov RS; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):49-53. PubMed ID: 2239005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of various morphological and biological properties of bacteria of the genus Proteus].
    Gabidullin ZG; Gimranov MG; Nikil'din IB; Ianbaeva KhA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):15-7. PubMed ID: 3907216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proticine typing of serologically defined Proteus strains.
    Csiszár K; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ureases of Proteus strains in relation to virulence for the urinary tract.
    Senior BW; Bradford NC; Simpson DS
    J Med Microbiol; 1980 Nov; 13(4):507-12. PubMed ID: 7001026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.